Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 305,667,944
- Total 13F shares
- 138,959,875
- Share change
- +6,384,838
- Total reported value
- $1,408,301,843
- Put/Call ratio
- 52%
- Price per share
- $10.13
- Number of holders
- 198
- Value change
- +$64,970,441
- Number of buys
- 107
- Number of sells
- 76
Report period
Q4 2022
Institutions
198
Top holders
10
ABCL full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00288U106
Recent filing periods:
Top shareholders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
|
Company |
4.4%
|
13,357,668
|
$132,109,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.1%
|
12,569,140
|
$124,310,000 | — | 30 Sep 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
3.5%
|
10,777,597
|
$106,590,435 | — | 30 Sep 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.4%
|
10,450,180
|
$103,352,000 | — | 30 Sep 2022 | |
| Capital World Investors |
13F
|
Company |
3.1%
|
9,580,759
|
$94,754,000 | — | 30 Sep 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.4%
|
4,180,768
|
$41,348,000 | — | 30 Sep 2022 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
1.3%
|
4,105,095
|
$40,599,000 | — | 30 Sep 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.3%
|
4,101,471
|
$40,564,000 | — | 30 Sep 2022 | |
| Founders Fund VII Management, LLC |
13F
|
Company |
1.2%
|
3,773,530
|
$37,320,000 | — | 30 Sep 2022 | |
| GUARDIAN CAPITAL ADVISORS LP |
13F
|
Company |
1.2%
|
3,736,414
|
$40,129,000 | — | 30 Sep 2022 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
1.1%
|
3,285,022
|
$32,488,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
3,210,819
|
$31,755,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.98%
|
2,980,803
|
$29,480,000 | — | 30 Sep 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.91%
|
2,775,359
|
$27,448,000 | — | 30 Sep 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.69%
|
2,104,041
|
$20,809,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
1,985,197
|
$19,633,000 | — | 30 Sep 2022 | |
| Casdin Capital, LLC |
13F
|
Company |
0.54%
|
1,650,000
|
$16,319,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
1,507,248
|
$14,907,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.39%
|
1,200,538
|
$11,873,000 | — | 30 Sep 2022 | |
| Novo Holdings A/S |
13F
|
Company |
0.37%
|
1,126,915
|
$11,145,000 | — | 30 Sep 2022 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.36%
|
1,091,505
|
$10,795,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.36%
|
1,088,473
|
$10,766,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.29%
|
878,892
|
$8,692,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.28%
|
869,304
|
$8,597,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
808,656
|
$7,997,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
771,244
|
$7,627,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.23%
|
703,010
|
$6,951,000 | — | 30 Sep 2022 | |
| Man Group plc |
13F
|
Company |
0.22%
|
665,422
|
$6,581,000 | — | 30 Sep 2022 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.22%
|
659,750
|
$6,525,000 | — | 30 Sep 2022 | |
| ArchPoint Investors |
13F
|
Company |
0.2%
|
617,213
|
$6,104,000 | — | 30 Sep 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.19%
|
583,981
|
$5,776,000 | — | 30 Sep 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.19%
|
575,262
|
$5,689,000 | — | 30 Sep 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.17%
|
527,660
|
$6,361,691 | — | 30 Sep 2022 | |
| NORGES BANK |
13F
|
Company |
0.17%
|
522,410
|
$5,166,635 | — | 30 Sep 2022 | |
| Belmont Capital, LLC |
13F
|
Company |
0.17%
|
510,000
|
$5,044,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.16%
|
500,130
|
$4,947,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.16%
|
496,548
|
$4,911,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.15%
|
467,700
|
$4,626,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
456,947
|
$4,520,000 | — | 30 Sep 2022 | |
| Founders Fund Growth Management, LLC |
13F
|
Company |
0.13%
|
407,017
|
$4,025,000 | — | 30 Sep 2022 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.13%
|
404,171
|
$3,997,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
401,217
|
$3,968,000 | — | 30 Sep 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.12%
|
354,397
|
$3,505,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.11%
|
343,926
|
$3,401,000 | — | 30 Sep 2022 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.11%
|
327,619
|
$3,240,000 | — | 30 Sep 2022 | |
| TWINBEECH CAPITAL LP |
13F
|
Company |
0.11%
|
326,451
|
$3,229,000 | — | 30 Sep 2022 | |
| Gruss & Co., LLC |
13F
|
Company |
0.1%
|
308,570
|
$3,052,000 | — | 30 Sep 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
287,512
|
$2,843,000 | — | 30 Sep 2022 | |
| Aberdeen Group plc |
13F
|
Company |
0.09%
|
275,432
|
$2,724,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
236,398
|
$2,338,000 | — | 30 Sep 2022 |
Institutional Holders of AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) as of Q4 2022
As of 31 Dec 2022,
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) was held by
198 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
138,959,875 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, BlackRock Inc., Voya Investment Management LLC, Voya Investment Management LLC, BAKER BROS. ADVISORS LP, Capital World Investors, ORBIMED ADVISORS LLC, HARVARD MANAGEMENT CO INC, CREDIT SUISSE AG/, and Founders Fund VII Management, LLC.
This page lists
198
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
185
Q4 2022 holders
198
Holder diff
13
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.